Rima Hajjo

Adjunct Associate Professor

University of North Carolina at Chapel Hill

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Rima Hajjo is an Adjunct Associate Professor at The University of North Carolina at Chapel Hill, United States. Her research spans a diverse range of areas, including the polypharmacological landscape of BCR-ABL inhibitors, anticancer agent development, and epidemiological analyses related to COVID-19. She has recently contributed to the understanding of mpox management, advancements in Alzheimer's disease research, and the targeting of human proteins for antiviral drug discovery.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (1)

Aktham Mestareehi

Wright State University

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Rima Hajjo

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

Computational Insights into the Polypharmacological Landscape of BCR-ABL Inhibitors: Emphasis on Imatinib and Nilotinib

Exploring Carboxamide Derivatives as Promising Anticancer Agents: Design, In Vitro Evaluation, and Mechanistic Insights

Advancing the understanding and management of Mpox: insights into epidemiology, disease pathways, prevention, and therapeutic strategies

Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012–2024)

Epidemiology Analysis of COVID‐19 Data and Associated Effects of Pandemic Containment Procedures, Viral Variants, and Vaccines: Lessons Learned From Middle Eastern Jordan’s Experience

A Critical Assessment of COVID-19 Genomic Vaccines

Identifying a causal link between prolactin signaling pathways and COVID-19 vaccine-induced menstrual changes

Network biology of lapatinib resistance in different types of HER2-positive breast cancers informs the prioritization of the combination anticancer treatments as anti-resistance interventions

Targeting Human Proteins for Antiviral Drug Discovery and Repurposing Efforts: A Focus on Protein Kinases

A Review of the Recent Advances in Alzheimer’s Disease Research and the Utilization of Network Biology Approaches for Prioritizing Diagnostics and Therapeutics

Collaborators (1)

Aktham Mestareehi

Make your next move.